Brand Insights - Thought Leadership | Paid Program
Roshawn Blunt, Brand Insights Contributor, Managing Director of 1798, a Fingerpaint company
Advertisement
We’re 220+ strong, fully independent, and ready to handle any healthcare marketing challenge you care to throw at us.
Articles by Roshawn Blunt, Brand Insights Contributor, Managing Director of 1798, a Fingerpaint company
Brand Insights - Thought Leadership from Marketers I Paid Program
Why it’s important to integrate patient assistance programs for cell and gene therapies into the overall clinical development plan.
Brand Insights - Thought Leadership from Marketers I Paid Program
New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
Advertisement
Latest Updated Articles
- Solving Access Challenges in Today’s Market
April 30th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5